Researcher.Life Logo

Rational Pharmacotherapy in Cardiology : Impact Factor & More

eISSN: 2225-3653pISSN: 1819-6446
JournalOpen Access

Key Metrics

CiteScore
0.9
H-Index
11
SJR
Q4Pharmacology (medical)
SNIP
0.32
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Rational Pharmacotherapy in Cardiology

Rational Pharmacotherapy in Cardiology Journal Specifications

Overview
Publisher SOC CARDIOLOGY RUSSIAN FEDERAT
Language Russian,English
Frequency Bi-monthly
Publication Time6
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian,English
Society/Institute/SponsorRussian Society of Cardiology
FrequencyBi-monthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Rational Pharmacotherapy in Cardiology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Rational Pharmacotherapy in Cardiology

Pulmonary hypertension due to chronic heart failure of ischemic genesis: clinical phenotypes determined by the right ventricular-pulmonary artery coupling
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Predictors of acute kidney injury after coronary artery bypass grafting in patients with non-ST-segment elevation acute coronary syndrome
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Prediction of left main coronary artery lesion in patients with stable coronary artery disease using artificial intelligence technology
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Inappropriate prescribing in patients with cardiovascular diseases and non-cardiac multimorbidity (outpatient registry data)
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Sodium-glucose cotransporter 2 inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
The role of glucagon-like peptide-1 receptor agonists in the treatment of dyslipidemia in patients with overweight and obesity (review)
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Pulmonary hypertension due to chronic heart failure of ischemic genesis: clinical phenotypes determined by the right ventricular-pulmonary artery coupling
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Predictors of acute kidney injury after coronary artery bypass grafting in patients with non-ST-segment elevation acute coronary syndrome
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Prediction of left main coronary artery lesion in patients with stable coronary artery disease using artificial intelligence technology
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Inappropriate prescribing in patients with cardiovascular diseases and non-cardiac multimorbidity (outpatient registry data)
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
Sodium-glucose cotransporter 2 inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology
The role of glucagon-like peptide-1 receptor agonists in the treatment of dyslipidemia in patients with overweight and obesity (review)
  • 11 Apr 2026
  • Rational Pharmacotherapy in Cardiology

FAQs on Rational Pharmacotherapy in Cardiology